Results 71 to 80 of about 8,126 (187)

Cityscapes in Roman Painting: The Amphitheater Riot Fresco as a Piece of “Popular Art”

New Classicists, 2020
The famous Riot Fresco from Pompeii (c. A.D. 62-79) depicts the infamous A.D. 59 rumble between rival Pompeians and Nucerians in and around the formers’ Amphitheater.
Kevin Stuart Lee
doaj  

Issue Information

International Wound Journal, Volume 23, Issue 9, September 2026.
wiley   +1 more source

Masolino et Masaccio : technique et style

Perspective, 2006
Neville Rowley
doaj   +1 more source

Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysis. [PDF]

Oncologist
Pfeiffer P, Cremolini C, Ducreux M, Osterlund P, Ronnebaum S, Akin-Fajiye M, Paly V, Hernandez L, Elez E.   +8 more
europepmc   +1 more source

A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in Spain. [PDF]

Clinicoecon Outcomes Res
Fernández A, González Astorga B, Rodríguez N, Safont MJ, Castro Albarrán P, Mareque M, Oyagüez I.   +6 more
europepmc   +1 more source

Robust framework for adaptive field-of-view automatic segmentation in vaginal brachytherapy for endometrial cancer. [PDF]

Phys Imaging Radiat Oncol
Casamitjana A, Gómez Fresco AM, Candela-Juan C, Tudela R, Sala-Llonch R, López SM, Noorian F, Rovirosa A, Niñerola-Baizán A, Herreros A.   +9 more
europepmc   +1 more source

Cardiovascular risk and cognitive performance: A population-based cross-sectional study (NEDICES2-RISK). [PDF]

PLoS One
Tapias-Merino E, De Hoyos-Alonso MDC, Rubio-Serrano J, Arregui-Gallego B, Gefaell-Larrondo I, Rodríguez-Sánchez E, Contador I, Sanz-Cuesta T, Bermejo-Pareja F, Del Cura-González I, NEDICES2-RISK Group.   +10 more
europepmc   +1 more source

Interpreting the evidence base for fruquintinib in refractory metastatic colorectal cancer. [PDF]

J Gastrointest Oncol
Udaikumar J, Shaukat A.
europepmc   +1 more source

Critical appraisal of "Fruquintinib in less pretreated patients: multivariate profile-matching analysis of FRESCO-2 to FRESCO". [PDF]

Ann Med Surg (Lond)
Amjad A, Khalid M.
europepmc   +1 more source

Fruquintinib in refractory metastatic colorectal cancer: separating randomized trial evidence from observational data. [PDF]

J Gastrointest Oncol
Koulaouzidis G, Koulaouzidis A, Marlicz W.   +2 more
europepmc   +1 more source